Data / Form D filings / Silo Pharma, Inc.
Silo Pharma, Inc.: Form D filings
Silo Pharma, Inc., a pharmaceuticals company in Sarasota, FL, filed 11 Form D notices with the SEC between 2011 and 2026. The latest, on July 14, 2026, reports $4 million sold of a $4 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 677 N. WASHINGTON BOULEVARD, Sarasota, FL, 34236
- Phone
- (718) 400-9031
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1514183
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 14, 2026 | New notice | $4,000,015 | $4,000,015 | 4 | Jul 9, 2026 | sec.gov | |
| Aug 2, 2024 | New notice | $2,296,880 | $2,296,880 | 2 | Jul 18, 2024 | sec.gov | |
| Jun 11, 2024 | New notice | $2,077,409 | $2,077,409 | 3 | Jun 4, 2024 | sec.gov | |
| Feb 22, 2021 | New notice | $4,276,000 | $4,276,000 | 47 | Feb 12, 2021 | sec.gov | |
| May 8, 2020 | New notice | $2,500,000 | $2,399,500 | $100,500 | 46 | Apr 28, 2020 | sec.gov |
| Dec 18, 2019 | New notice | $2,000,000 | $115,000 | $1,885,000 | 3 | Nov 26, 2019 | sec.gov |
| Dec 18, 2018 | New notice | $200,000 | $24,500 | $175,500 | 0 | Yet to occur | sec.gov |
| Jul 7, 2014 | New notice | $3,000,000 | $435,000 | $2,565,000 | 6 | Jul 1, 2014 | sec.gov |
| Oct 11, 2013 | Amendment | $2,000,000 | $1,000,000 | $1,000,000 | 12 | Sep 10, 2013 | sec.gov |
| Jun 7, 2013 | New notice | $2,000,000 | $0 | $2,000,000 | 0 | Yet to occur | sec.gov |
| Nov 22, 2011 | New notice | $100,000 | $6,560 | $93,440 | 36 | Oct 17, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Eric Weisblum | Executive Officer, Director | Chief Executive Officer |
| Daniel Ryweck | Executive Officer | Chief Financial Officer |
| Wayne Linsley | Director | |
| Kevin Munoz | Director | |
| Jeff Pavell | Director |
Other pharmaceuticals companies in Florida that filed recently
- DalCor Pharmaceuticals US, LLC $7 million · Aug 28, 2026
Every Form D from the week of Jul 13, 2026 · All recent filings in Florida · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Silo Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.